Skip to main content
TipRanks
Go Ultimate75% OFF

Sundaram Multi Pap Limited (SUNDARAM) AI Stock Analysis

0 Followers
IN:SUNDARAM

Sundaram Multi Pap Limited

(NSE:SUNDARAM)

Select Model
Rating:51Neutral
Price Target:INR 1.00â–¼(-2.91% Downside)
Action:reiterated
Date:11/19/26

The score is held back primarily by unstable operating performance and weak cash generation (negative operating and free cash flow in 2026) alongside a broadly bearish technical trend (price below key moving averages and negative MACD). These risks are partially offset by a relatively sound balance sheet with improving leverage and a moderate P/E valuation.

Positive Factors
Revenue ExpansionThe multi-year revenue expansion indicates that the business has regained demand and maintained commercial growth through 2026. Continued top-line progress can support operating scale, strengthen market presence, and provide a foundation for improved profitability if margins stabilize.
Negative Factors
Negative Cash GenerationNegative operating and free cash flow means recent accounting earnings did not convert into internally generated liquidity. If this persists, Sundaram may have less capacity to fund operations and investment independently, increasing reliance on balance-sheet resources or external financing.

Sundaram Multi Pap Limited (SUNDARAM) vs. iShares MSCI India ETF (INDA)

-50%-40%-30%-20%-10%0%10%IN:SUNDARAM-45.21%INDA-2.43%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
INR 483.36M
Dividend Yield
―
Average Volume (3M)
87.05K
Price to Earnings (P/E)
17.9
Beta (1Y)
1.09
Revenue Growth
16.85%
EPS Growth
―
Country
India
Employees
476
Sector
General
Sector Strength
55
Industry
Paper, Lumber & Forest Products

Sundaram Multi Pap Limited Business Overview & Revenue Model

Company Description

Sundaram Multi Pap Limited is an Indian company dedicated to the creation, production, and distribution of paper-based stationery items, primarily catering to students throughout India. The company's extensive inventory features a wide array of books...

Sundaram Multi Pap Limited Financial Statement Overview

Summary

Balance sheet strength is a positive (improving leverage with debt-to-equity around ~0.23 in 2026), but operating results and cash conversion are unstable. Profitability swung from profits to losses (2024–2025) and only a small profit in 2026, with sharply compressed margins. The biggest concern is 2026 turning to negative operating cash flow and negative free cash flow, suggesting liquidity/funding pressure if it persists.

Income Statement

52Neutral

Balance Sheet

68Positive

Cash Flow

43Neutral
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue1.46B1.37B1.27B1.27B1.14B703.58M
Gross Profit243.71M212.09M339.35M209.04M284.71M235.39M
EBITDA72.83M83.64M18.91M27.23M103.34M132.61M
Net Income39.41M31.80M-51.21M-50.82M25.89M39.11M
Balance Sheet
Total Assets01.16B1.22B1.35B1.38B1.46B
Cash, Cash Equivalents and Short-Term Investments2.01M2.01M211.03M2.23M26.04M3.63M
Total Debt0211.42M268.68M333.90M346.19M393.68M
Total Liabilities-906.92M250.38M340.64M419.45M403.71M510.26M
Stockholders Equity906.92M906.92M875.38M926.31M977.03M949.81M
Cash Flow
Free Cash Flow-66.30M-81.41M68.89M34.87M108.36M49.50M
Operating Cash Flow-66.30M-34.11M68.89M54.07M113.52M54.06M
Investing Cash Flow9.13M-48.74M161.21M-19.35M-5.78M-3.18M
Financing Cash Flow-62.17M-57.26M-90.21M-57.84M-86.03M-50.97M

Sundaram Multi Pap Limited Technical Analysis

Technical Analysis SentimentNegative
Last Price1.03

Price Trends

50DMA1.09Negative
100DMA1.17Negative
200DMA1.30Negative

Market Momentum

MACD-0.02Negative
RSI44.46Neutral
STOCH28.06Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:SUNDARAM, the sentiment is Negative. The current price of 1.03 is below the 20-day moving average (MA) of 1.04, below the 50-day MA of 1.09, and below the 200-day MA of 1.30, indicating a bearish trend. The MACD of -0.02 indicates Negative momentum. The RSI at 44.46 is Neutral, neither overbought nor oversold. The STOCH value of 28.06 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:SUNDARAM.

Sundaram Multi Pap Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IN:SUNDARAM against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:STARPAPERIN:STARPAPER68NeutralINR 2.37B15.06―1.64%-5.05%-59.30%
IN:EMAMIPAPIN:EMAMIPAP60NeutralINR 6.87B5.21―2.91%16.70%610.58%
IN:RUCHIRAIN:RUCHIRA59NeutralINR 2.86B13.67―2.60%2.29%-68.88%
IN:GENUSPAPERIN:GENUSPAPER56NeutralINR 2.59B14.56――-0.99%144.43%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
IN:SUNDARAMIN:SUNDARAM51NeutralINR 492.83M17.86――16.85%―
IN:ORIENTPPRIN:ORIENTPPR43NeutralINR 3.18B-4.50――-1.00%-174.77%

* General Sector Average

Performance Comparison

-40%-20%0%20%40%IN:SUNDARAMIN:EMAMIPAPIN:GENUSPAPERIN:ORIENTPPRIN:RUCHIRAIN:STARPAPERDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
IN:SUNDARAM and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:SUNDARAMSundaram Multi Pap Limited1.03-0.79-43.41%
IN:EMAMIPAPEmami Paper Mills Limited111.3022.5825.45%
IN:GENUSPAPERGenus Paper & Boards Ltd10.14-3.64-26.42%
IN:ORIENTPPROrient Paper & Industries Ltd.14.67-8.50-36.69%
IN:RUCHIRARuchira Papers Limited96.05-19.98-17.22%
IN:STARPAPERStar Paper Mills Ltd.152.00-9.50-5.88%

Sundaram Multi Pap Limited Corporate Events

Sundaram Multi Pap Secures Strong Shareholder Backing at 32nd AGM

Oct 1, 2026

Sundaram Multi Pap Limited reported the outcomes of its 32nd Annual General Meeting held on September 29, 2026, conducted via video conferencing and other audio-visual means. The company submitted the scrutinizer’s report and detailed voting results...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 19, 2026